Raw Data for the article: Portal vein puncture-related complications during transjugular intrahepatic portosystemic shunt creation: Colapinto needle set vs Rösch-Uchida needle set

Transjugular portal vein puncture is considered the riskiest step in TIPS creation with possible incidence of portal vein puncture-related complications (PVPC). The Colapinto and the Rösch-Uchida needle sets are two different needle sets currently available. To date, there have been no randomized control trials or systematic reviews which compare the incidence of PVPC when using the two different needle sets. The aim of this literature review is to assess the rate of PVPC associated with the different needle sets used in the creation of TIPS. From the described search, 1500 articles were identified and 34 met the inclusion criteria. Outcome measured was the prevalence of PVPC using the different needle sets. Overall 212 (3.6%) PVPC were reported in 5865 patients; 142 (3.5%) reported in 4000 cases using the Rösch-Uchida set and 70 (3.7%) in 1865 patients using the Colapinto set (p = 0.69). PVPC in TIPS creation are not related to the choice of needle set used in the procedure. To our knowledge, this is the first review of its kind, the results of which support the theory that while the rate of PVPC is influenced by many factors, choice of needle set does not seem to be one of them.经颈静脉门静脉穿刺被视为经颈静脉肝内门体分流术（Transjugular Intrahepatic Portosystemic Shunt，TIPS）构建过程中风险最高的步骤，其可能引发与门静脉穿刺相关的并发症（Portal Vein Puncture Complications，PVPC）。目前临床可用的穿刺套件主要有Colapinto与Rösch-Uchida两种类型。截至目前，尚无针对这两种穿刺套件所引发的PVPC发生率开展对比研究的随机对照试验或系统综述。本文献综述旨在评估TIPS构建过程中，使用不同穿刺套件时相关PVPC的发生率。经既定检索流程，共检索到1500篇相关文献，其中34篇符合纳入标准。本研究的结局指标为不同穿刺套件对应的PVPC患病率。总计5865例患者中报告了212例PVPC（占比3.6%）：其中使用Rösch-Uchida套件的4000例患者中报告142例（占比3.5%），使用Colapinto套件的1865例患者中报告70例（占比3.7%）（p = 0.69）。TIPS构建过程中的PVPC发生率与所选用的穿刺套件类型并无关联。据我们所知，本研究为首项此类系统综述，其结果支持如下理论：尽管PVPC发生率受多种因素影响，但穿刺套件的选择并非其中之一。